Company: AEGOF
Filing Date: 2025-05-15
Form Type: F-3ASR
Source: 0001193125-25-120338
Chunk: 37

Company: AEGON LTD.
Filing Date: 2025-05-15
Form: F-3ASR
Chunk 37
---
 of warrants. The following is a summary of the general terms of the warrants. Each time that we issue warrants pursuant to this prospectus we will file with the SEC a prospectus supplement, and, if applicable, a pricing supplement, that you should read carefully. The prospectus supplement and, if applicable, the pricing supplement will contain the specific terms applicable to those warrants. The terms presented here, together with the specific terms contained in the applicable prospectus supplement and, if applicable, the pricing supplement will be a description of the material terms of the warrants. General We will describe in the related prospectus supplement or, if applicable, the pricing supplement the terms of each series of warrants to purchase securities, which may include debt securities, common shares or the equity or debt of issuers unaffiliated with us, the warrant agreement relating to the warrants offered and the warrant certificates representing the warrants offered. These terms will include some or all of the following:

| • |     | the title of the warrants offered; |

| • |     | the securities, which may include debt securities, common shares or the equity or debt of issuers unaffiliated 
 with us, for which you may exercise the warrants;                                                              |

| • |     | the aggregate number of the warrants; |

| • |     | the number of securities that you may purchase upon exercise of each warrant, and the price or prices at which we 
 will issue the warrants;                                                                                          |

| • |     | the currency or currencies investors may use to pay for the warrants; |

| • |     | the procedures and conditions relating to the exercise of the warrants; |

| • |     | the designation and terms of any related securities issued with the warrants, and the number of warrants issued 
 with each security;                                                                                             |

| • |     | the date, if any, from which you may separately transfer the warrants and the related securities; |

| • |     | the date on which your right to exercise the warrants commences, and the date on which your right expires; |

| • |     | whether we will issue the warrants or the underlying securities in registered form or bearer form; |

| • |     | information with respect to book-entry procedures, if any; |

| • |     | the maximum or minimum number of warrants which you may exercise at any time; |

| • |     | if applicable, a discussion of material United States federal income tax considerations; |

| • |     | a description of your rights to institute and maintain any